je.st
news
Tag: merck
Merck Statement regarding Role of PNEUMOVAX 23 (Pneumococcal Vaccine Polyvalent) in Updated ACIP Recommendations for Pneumococcal Vaccination in Adults
2014-08-13 23:58:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today provided the following statement regarding the U.S. Centers for Disease Control and Preventions (CDCs) Advisory Committee on Immunization Practices (ACIPs) updated pneumococcal vaccine recommendations for adults 65 years of age and older. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Skip Irvine, 215-652-6059orInvestors:Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
updated
statement
role
FDA approves new sleeping drug from Merck
2014-08-13 23:46:01| Biotech - Topix.net
Merck & Co. Inc. has won federal approval for a new type of sleeping pill designed to help people with insomnia stay asleep.
Tags: drug
sleeping
fda
approves
Merck Publishes 2013 Global Corporate Responsibility Report
2014-08-05 19:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today issued its 2013 global corporate responsibility report. The report, available at www.merckresponsibility.com, focuses on the companys corporate responsibility activities, progress and performance during 2013 in four priority areas where Merck is positioned to have a positive impact: Access to Health, Environmental Sustainability, Employees and Ethics and Transparency. Highlights from the 2013 report include: Language: English Contact: For MerckMedia:Lainie Keller, 908-423-4187orInvestors:Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: report
global
corporate
responsibility
Merck Completes Tender Offer to Acquire Idenix
2014-08-05 12:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced the successful completion of the tender offer for all of the outstanding shares of common stock of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) at a purchase price of $24.50 per share. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461orInvestors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: offer
acquire
tender
completes
Earnings: UPS profit slides; Pfizer tops estimates; Merck doubles; Aetna inches higher
2014-07-29 22:01:00| Trucking - Topix.net
United Parcel Service driver Marty Thompson starts his truck up after making a delivery in Cumming, Ga.
Tags: higher
ups
profit
estimates
Sites : [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] next »